Published: Jan. 15, 2026 at 11:51\u202fa.m. ET<\/p>\n
Millions of Americans have tried GLP-1s, but some people find that the weight-loss drugs have too many side effects, are expensive or just don\u2019t work for them.<\/p>\n
Patients also have to deal with changes to their health insurance at the start of a new year, and more employers have withdrawn coverage of the pricey medications. About half of the people who stop taking GLP-1s, like Eli Lilly\u2019s LLY<\/a> Zepbound or Novo Nordisk\u2019s NVO<\/a> Wegovy, discover that they gain back all the weight they lost within two years.<\/p>\n","protected":false},"excerpt":{"rendered":"Published: Jan. 15, 2026 at 11:51\u202fa.m. ET Millions of Americans have tried GLP-1s, but some people find that…\n","protected":false},"author":2,"featured_media":698402,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[210350,210351,108800,181283,4179,17837,105,3941,388,3391,202005,179184,5167,4326,210353,210348,210349,370,5489,51341,210347,5494,153446,28415,16,15,10891,1530,10892,210352,180571,34627],"class_list":{"0":"post-698401","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-boston-scientific-corp","9":"tag-bsx","10":"tag-eli-lilly-co","11":"tag-gcapi","12":"tag-general-news","13":"tag-glp1","14":"tag-health","15":"tag-health-care","16":"tag-lifestyle","17":"tag-living","18":"tag-living-lifestyle","19":"tag-lly","20":"tag-manufacturing","21":"tag-medication","22":"tag-mental-fitness","23":"tag-novo-nordisk-a-s-adr","24":"tag-nvo","25":"tag-ozempic","26":"tag-pharmaceuticals","27":"tag-physical","28":"tag-physical-mental-fitness","29":"tag-political","30":"tag-political-general-news","31":"tag-synd","32":"tag-uk","33":"tag-united-kingdom","34":"tag-wegovy","35":"tag-weight-management","36":"tag-weightloss","37":"tag-ww","38":"tag-ww-international-inc","39":"tag-zepbound"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/698401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=698401"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/698401\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/698402"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=698401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=698401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=698401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}